Investment
Features
FeesSafety
Academy
More
Pluang+

MicroStrategy boosts USD reserves to $6.7B, pausing Bitcoin buys to manage liquidity and dividends.

Market News
24 Aug 2026
Crypto Briefing
View Source
Neutral
MicroStrategy boosts USD reserves to $6.7B, pausing Bitcoin buys to manage liquidity and dividends.

MicroStrategy, the largest corporate Bitcoin holder, increased its US dollar reserves by $1.9 billion to $6.7 billion through equity sales, pausing Bitcoin purchases to focus on liquidity and dividend payments. The company maintains its Bitcoin holdings steady, avoiding selling BTC to fund dividends, which are paid in dollars. This strategy reduces immediate Bitcoin market demand but leaves MicroStrategy with a large cash reserve ready to deploy if market conditions improve. This dual-reserve approach aims to reassure different investor groups about the company's financial stability.

More News

UBS Group AG surpasses 5% ownership in Bang & Olufsen shares as of October 9, 2026

UBS Group AG surpasses 5% ownership in Bang & Olufsen shares as of October 9, 2026

UBS Group AG has officially notified that it holds 7,768,727 shares in Bang & Olufsen A/S, representing 5.27% of the company's total share capital and voting rights as of October 9, 2026. This disclosure is made in compliance with the Danish Capital ...

Market News
Neutral
1 hour ago
Admiral Group directors acquire shares via dividend reinvestment plan on Oct 14, 2026

Admiral Group directors acquire shares via dividend reinvestment plan on Oct 14, 2026

On October 14, 2026, Michael Brierley, a Non-Executive Director of Admiral Group plc, and his wife Rachel Brierley acquired shares of the company through a dividend reinvestment trading plan. The transactions involved purchasing ordinary shares at pr...

Company Fundamentals
Neutral
1 hour ago
Norsk Hydro to release Q3 2026 results on Oct 23 with live webcast presentation.

Norsk Hydro to release Q3 2026 results on Oct 23 with live webcast presentation.

Norsk Hydro will publish its third-quarter 2026 financial results on October 23, 2026, at 07:00 CEST. The company's CEO and CFO will present the results via a live webcast at 08:30 CEST the same day, allowing investors to ask questions online. There ...

Company Fundamentals
Neutral
1 hour ago
FDA approves Roche’s Enspryng as first at-home treatment for thyroid eye disease

FDA approves Roche’s Enspryng as first at-home treatment for thyroid eye disease

The FDA has approved Roche's Enspryng (satralizumab) as the first and only at-home subcutaneous treatment for adults with thyroid eye disease (TED). This approval follows positive results from Phase III SatraGO-2 trials showing significant reductions...

Market News
Bullish
2 hours ago
NEAR Protocol price rises 12% after Helius CEO joins NEAR Foundation Council

NEAR Protocol price rises 12% after Helius CEO joins NEAR Foundation Council

NEAR Protocol's price surged over 12% in 24 hours, trading above $5.20 following the appointment of Helius CEO Mert Mumtaz to the NEAR Foundation Council. This move supports governance as the Foundation expands privacy and cross-chain trading feature...

Technical Signals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App